Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Bio Medical Devices
- Sub-Industry: N/A
- Symbol: NASDAQ:NVTRV
- CUSIP: N/A
- Web: www.qiggroup.com/
- Trailing P/E Ratio:
- P/E Growth:
- Net Margins: -260.36%
- Return on Equity: -63.97%
- Return on Assets: -47.24%
Frequently Asked Questions for Nuvectra Corp (NASDAQ:NVTRV)
What is Nuvectra Corp's stock symbol?
Nuvectra Corp trades on the NASDAQ under the ticker symbol "NVTRV."
Who are some of Nuvectra Corp's key competitors?
Some companies that are related to Nuvectra Corp include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Merck KGaA (MKGAY), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), ResMed (RMD), Omnicare (OCR), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), NMC Health PLC (NMC), Catalent (CTLT), Cotiviti Holdings (COTV), Puma Biotechnology (PBYI) and Opko Health (OPK).
How do I buy Nuvectra Corp stock?
MarketBeat Community Rating for Nuvectra Corp (NASDAQ NVTRV)MarketBeat's community ratings are surveys of what our community members think about Nuvectra Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Shares of Nuvectra Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
Consensus Ratings for Nuvectra Corp (NASDAQ:NVTRV) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Nuvectra Corp (NASDAQ:NVTRV)
(Data available from 7/20/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|6/3/2016||Sterne Agee CRT||Reiterated Rating||Buy||N/A|
Earnings History for Nuvectra Corp (NASDAQ:NVTRV)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Nuvectra Corp (NASDAQ:NVTRV)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Nuvectra Corp (NASDAQ:NVTRV)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Nuvectra Corp (NASDAQ:NVTRV)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Nuvectra Corp (NASDAQ:NVTRV)
Latest Headlines for Nuvectra Corp (NASDAQ:NVTRV)
No headlines for this company have been tracked by MarketBeat.com
Nuvectra Corp (NVTRV) Chart for Thursday, July, 20, 2017